Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block

被引:81
|
作者
Lupoglazoff, JM
Cheav, T
Baroudi, G
Berthet, M
Denjoy, L
Cauchemez, B
Extramiana, F
Chahine, M
Guicheney, P
机构
[1] Hop Robert Debre 48, Serv Cardiol Pediat, F-75019 Paris, France
[2] Hop Pitie Salpetriere 47, Inst Myol, INSERM, U523, Paris, France
[3] Laval Hosp, Quebec Heart Inst, Laval, PQ, Canada
[4] Hop Lariboisiere 2, Serv Cardiol, Paris, France
关键词
arrhythmias; clinical genetics; ion channels;
D O I
10.1161/hh1401.095087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heterozygous mutations in genes encoding cardiac ionic channel subunits KCNQ1, HERG, SCN5A, KCNE1, and KCNE2 are causally involved in the dominant form of long-QT syndrome (LQTS) while homozygous mutations in KCNQ1 and KCNE1 cause LQTS with or without congenital deafness. In addition, two homozygous HERG mutations have been associated with severe LQTS with functional atrioventricular conduction anomalies in young children. A 2:1 atrioventricular block (AVB) with a major QTc prolongation (526 ms) was evidenced in a 5-year-old boy referred for syncope and seizure. LQTS was diagnosed and beta-blocking therapy initiated leading to normal atrioventricular conduction. Electrophysiological study provided support that location of the AVB was infra-Hisian. DNA analysis was performed in the proband and in asymptomatic family members. A novel missense mutation, V1777M, in the early C-terminal domain of SCN5A was identified. The proband was homozygous while the parents and two siblings were heterozygous carriers. Homozygote and heterozygote expression of the mutant channels in tsA201 mammalian cells resulted in a persistent inward sodium current of 3.96 +/- .83% and 1.49 +/-0.47% at -30 mV, respectively, which was dramatically reduced in the presence of tetrodotoxin. This study provides the first evidence for a homozygous missense mutation in SCN5A and suggests that LQTS with functional 2:1 AVB in young children, a severe phenotype associated with bad prognosis, may be caused by homozygous or heterozygous compound mutations not only in HERG but also in SCN5A. The full text of this article is available at http://www.circresaha.org.
引用
收藏
页码:E16 / E21
页数:6
相关论文
共 50 条
  • [1] Homozygous SCN5A mutation in long QT syndrome with functional 2:1 AV block
    Lupoglazoff, JM
    Cheav, T
    Baroudi, G
    Berthet, M
    Denjoy, I
    Chahine, M
    Guicheney, P
    CIRCULATION, 2001, 104 (17) : 752 - 752
  • [2] Congenital Long QT Syndrome and 2:1 Atrioventricular Block with a Mutation of the SCN5A Gene
    M. Miura
    H. Yamagishi
    Y. Morikawa
    R. Matsuoka
    Pediatric Cardiology, 2003, 24 : 70 - 72
  • [3] Congenital long QT syndrome and 2:1 atrioventricular block with a mutation of the SCN5A gene
    Miura, M
    Yamagishi, H
    Morikawa, Y
    Matsuoka, R
    PEDIATRIC CARDIOLOGY, 2003, 24 (01) : 70 - 72
  • [4] Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation
    Makita, N
    Otani, H
    Kitabatake, A
    Horie, M
    BIOPHYSICAL JOURNAL, 2002, 82 (01) : 88A - 88A
  • [5] Drug-induced Long-QT syndrome associated with a subclinical SCN5A mutation
    Makita, N
    Horie, M
    Nakamura, T
    Ai, T
    Sasaki, K
    Yokoi, H
    Sakurai, M
    Sakuma, I
    Otani, H
    Sawa, H
    Kitabatake, A
    CIRCULATION, 2002, 106 (10) : 1269 - 1274
  • [6] Homozyqotous mutation of the SCN5A gene responsible for a congenital long QT syndrome with 2/1 atrioventricular block
    Lupoglazoff, JM
    Denjoy, I
    Cheav, T
    Berthet, M
    Extramiana, F
    Cauchemez, B
    Villain, E
    Leenhardt, A
    Guicheney, P
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2002, 95 (05): : 440 - 446
  • [7] Homozygote SCN5A mutation in long QT-syndrome with functional 2:1 AV block
    Denjoy, I
    Lupoglazoff, JM
    Cheav, T
    Baroudi, G
    Berthet, M
    Chahine, M
    Guicheney, P
    EUROPEAN HEART JOURNAL, 2001, 22 : 424 - 424
  • [8] Drug-induced acquired Long-QT syndrome associated with a subclinical SCN5A mutation
    Makita, N
    Morie, M
    Ai, T
    Otani, H
    Sasaki, K
    Yokoi, H
    Kitabatake, A
    CIRCULATION, 2002, 106 (19) : 225 - 226
  • [9] Effects of flecainide in patients with new SCN5A mutation - Mutation-specific therapy for long-QT syndrome?
    Benhorin, J
    Taub, R
    Goldmit, M
    Kerem, B
    Kass, RS
    Windman, I
    Medina, A
    CIRCULATION, 2000, 101 (14) : 1698 - 1706
  • [10] SCN5A mutation responsible for type-3 long-QT syndrome associated with atrial fibrillation
    Benito, B.
    Lizotte, E.
    Barahona-Dussault, C.
    Brugada, P.
    Brugada, J.
    Brugada, R.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 177C - 178C